corpus.blog
56,966 blogs · 4,417,066 posts Claim your blog
Record · corpus.blog/posts/01a087d6-bd35-709e-876f-3fde0ac8008b

GLP-1 Drugs: Beyond Weight Loss

rochansinha.com · published 15 April 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at rochansinha.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
Links from this post
38
Words captured
1,354

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://www.nejm.org/doi/abs/10.1056/NEJMoa2416394
nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
nejm.org
https://clinicaltrials.gov/study/NCT05556512
clinicaltrials.gov
https://www.nejm.org/doi/full/10.1056/NEJMoa2410027
nejm.org
https://www.nature.com/articles/s41591-024-03374-z
nature.com
https://jamanetwork.com/journals/jamaoncology/fullarticle/2812769
jamanetwork.com
https://www.cnbc.com/2026/03/23/novo-nordisk-cheap-weight-loss-drugs-india-generic-ozempic-wegovy-semaglutide.html
cnbc.com
https://www.jacc.org/doi/10.1016/j.jacc.2018.06.082
jacc.org
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
nejm.org
https://jamanetwork.com/journals/jama/fullarticle/2777025
jamanetwork.com
https://jamanetwork.com/journals/jama/fullarticle/2777886
jamanetwork.com
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
nejm.org
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21
thelancet.com
https://www.nejm.org/doi/full/10.1056/NEJMoa1607141
nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa1901118
nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa2505928
nejm.org
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24
thelancet.com
https://pubmed.ncbi.nlm.nih.gov/39217564/
pubmed.ncbi.nlm.nih.gov
https://www.atherosclerosis-journal.com/article/S0021-9150(24
atherosclerosis-journal.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC10992717/
pmc.ncbi.nlm.nih.gov
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16366
dom-pubs.onlinelibrary.wiley.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC11898313/
pmc.ncbi.nlm.nih.gov
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16489
dom-pubs.onlinelibrary.wiley.com
https://link.springer.com/article/10.1186/s40364-025-00765-3
link.springer.com
https://www.asco.org/about-asco/press-center/news-releases/glp-1-receptor-agonists-may-modestly-reduce-risk-obesity-related-cancers-people-with-diabetes
asco.org
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25
thelancet.com
https://jamanetwork.com/journals/jamaoncology/article-abstract/2837870
jamanetwork.com
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1431292/full
frontiersin.org
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24
thelancet.com
https://www.science.org/content/article/breakthrough-2023
science.org
https://news.gallup.com/poll/696599/obesity-rate-declining.aspx
news.gallup.com
https://www.npr.org/sections/shots-health-news/2025/10/28/nx-s1-5587805/glp-1-ozempic-zepbound-gallup-obesity-rate
npr.org
https://www.cnbc.com/2026/02/04/eli-lilly-lly-earnings-q4-2025.html
cnbc.com
https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
nejm.org
https://www.prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-weight-loss-of-up-to-an-average-of-71-2-lbs-along-with-substantial-relief-from-osteoarthritis-pain-in-first-successful-phase-3-trial-302638804.html
prnewswire.com
https://www.nejm.org/doi/full/10.1056/NEJMp058106
nejm.org
https://pubmed.ncbi.nlm.nih.gov/36805018/
pubmed.ncbi.nlm.nih.gov